Suurtagalnimada SSRI-Cancer Link?

Cilmi-baareyaasha Waxay qeexaan in SSRs sida Prozac ay Korodho Khatarta Kansarka

Noocyada dawada lidka ku ah ee loo yaqaan SSRIs (Prozac, Luvox, Paxil, Zoloft, Celexa, Lexapro) ayaa suurtogal ah in ay kordhiso khatarta kansarka maskaxda, sida laga soo xigtay warbixintii 2002 dii.

Professor John Gordon oo ka tirsan Jaamicadda Birmingham ayaa sheegay in SSRs ay ku dhiirigelisay koritaanka Burkitt ee lymfoma , nooc ka mid ah kansar kaas oo saameeya habka lenfiga, ee tijaabooyinka tijaabada tubooyinka.

Waxaa la ogaaday in haddii ay saameyn karaan kobaca noocan ah kansarka waxay sidoo kale saameyn karaan kansarrada maskaxda si isku mid ah.

Farsamaynta ficilkan khatarta ugu weyn waxay tahay iyadoo la xakameynayo awoodda jidhka ee jidhka si loo dilo unugyada burooyinka. Gordon, oo natiijadiisa laga soo daabacay bogga "Blood", ayaa sheegay in serotonin uu yahay ciyaaryahan muhiim u ah dhiirigelinta apoptosis, dhimashada unugyada dabiiciga ah ee barnaamijka dabiiciga ah kaas oo keenaya kantaroolka kobaca unugyada. Haddii aan geeddi-socodkan lagu xakameynin unugyadaas, kaansarka ayaa laga yaabaa inuu kobciyo.

Lama garanayo in xogtaas la dhimi karo si ay ula jeedaan in bini-aadanku ay halis dheeraad ah ugu jiraan inay ku dhacdo kansarka. Illaa iyo hadda, isku-xirnaan la'aanta SSRI-cancer ayaa lagu arkay bukaan-socod eegtada iyo madaxda shirkadaha daroogada ayaa sheegaya in qiyaasta sare ee loo isticmaalo tijaabinta Gordon ayan bixin karin tilmaame la isku halleyn karo oo ku saabsan waxa ka dhacaya bukaan-socodka.

Daroogooyinka gaarka ah ee baaray Gordon waxay ahaayeen Prozac, Paxil iyo Celexa.

Xigasho:

Adamantios Serafeim, Gillian Grafton, Anita Chamba, Christopher D. Gregory, Randy D. Blakely, Norman G. Bowery, Nicholas M. Barnes, iyo John Gordon. "5-Hydroxytryptamine waxay wadataa apoptosis biopsylike unugyada Burkitt lymphoma: dib-u-dhac ku yimaada xakamaynta serotonin-ka ee xakamaynta." Dhiiga 2002 99: 2545-2553.